Muse cells show promise across a range of early
Author: Michael
TimePie’s 7th longevity forum will bring toget
The company’s gene therapy candidate aims to s
HAYA Therapeutics announced that the first cohort
CellProthera is advancing its CD34+ stem cell the
Kailera Therapeutics, listed on Nasdaq as KLRA an
Mayrlife Medical Health Resort Altaussee launched
Junevity will present new data at the American Ag
Arrowhead Pharmaceuticals reported fiscal second-
Rejuvenate Biomed has completed recruitment in it